Literature DB >> 2060448

Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population.

M I Harris1.   

Abstract

The prevalence of hypercholesterolemia, according to the guidelines of the National Cholesterol Education Program, has been determined in a national survey of diabetes and glucose intolerance. Rates of elevated total cholesterol in people with diabetes in the United States are only slightly greater than in those without diabetes after adjusting for age and sex. Nevertheless, high or borderline high total cholesterol is common in diabetes and is present in 70% of adults with diagnosed diabetes and 77% with undiagnosed diabetes in the U.S. population. Of these individuals, 95% have evidence of coronary heart disease or two or more risk factors for heart disease and should therefore have their low-density lipoprotein (LDL) cholesterol measured. Based on our national data, LDL cholesterol levels warranting dietary treatment for hypercholesterolemia would be expected in 85% of these people. Although elevated LDL cholesterol is uncommon in people with diabetes who have total cholesterol of less than 200 mg/dl, other risk factors for coronary heart disease are very frequent (100% of men, 73% of women), and low total and LDL cholesterol may mask low high-density lipoprotein cholesterol. Therefore, investigation of blood lipid levels and coronary heart disease risk factors should be routine in all patients with diabetes, and treatment strategies should include management of lipid disorders and the multiple other risk factors for coronary heart disease that are highly prevalent in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060448     DOI: 10.2337/diacare.14.5.366

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

Review 1.  Diabetic dyslipidaemia: current treatment recommendations.

Authors:  J D Best; D N O'Neal
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 2.  How does diabetes accelerate Alzheimer disease pathology?

Authors:  Catrina Sims-Robinson; Bhumsoo Kim; Andrew Rosko; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2010-09-14       Impact factor: 42.937

3.  Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians.

Authors:  Laurentia Mihardja; Uken Soetrisno; Sidartawan Soegondo
Journal:  J Diabetes Investig       Date:  2013-12-01       Impact factor: 4.232

4.  Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.

Authors:  O O Oyelola; A A Ajayi; R O Babalola; E A Stein
Journal:  J Natl Med Assoc       Date:  1995-02       Impact factor: 1.798

5.  Hyperlipidemia, increased lipid peroxidation and changes in antioxidant enzymes, Na(+)-K(+)-ATPase in erythrocytes of type 2 diabetic patients in andhra pradesh.

Authors:  R Giri; M M Kesavulu; B K Rao; V Ramana; C A Rao
Journal:  Indian J Clin Biochem       Date:  1999-07

6.  The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Authors:  Catrina Sims-Robinson; Anna Bakeman; Andrew Rosko; Rebecca Glasser; Eva L Feldman
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

Review 7.  Beta-glucans in the treatment of diabetes and associated cardiovascular risks.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Abdominal obesity, blood glucose and apolipoprotein B levels are the best predictors of the incidence of hypercholesterolemia (2001-2006) among healthy adults: the ATTICA study.

Authors:  Demosthenes B Panagiotakos; Christos Pitsavos; Yannis Skoumas; Yannis Lentzas; Labros Papadimitriou; Christina Chrysohoou; Christodoulos Stefanadis
Journal:  Lipids Health Dis       Date:  2008-03-31       Impact factor: 3.876

9.  Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Vasilios Papademetriou; Linda B Piller; Charles E Ford; David Gordon; Thomas J Hartney; Therese S Geraci; Efrain Reisin; Brian Montgomery Sumner; Nathan D Wong; Chuke Nwachuku; Puneet Narayan; Julian Haywood; Gabriel Habib
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.